Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schoemaker

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Neuropharmacology|August 1, 1989
Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transportersA M De Oliveira, H Schoemaker, A Segonzac, et al.
European Journal of Pharmacology|March 25, 1983
In vivo identification of calcium antagonist binding sites using [3H]nitrendipineH Schoemaker, H R Lee, W R Roeske, et al.
Neuropharmacology|July 31, 1999
Pharmacological studies on synthetic flavonoids: comparison with diazepamG Griebel, G Perrault, S Tan, et al.
Clinical Neuropharmacology|January 1, 1992
The serotonin re-uptake transporter as a target for antidepressant actionS Z Langer, D Graham, S Arbilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1983
beta-Endorphin and its metabolites stimulate motility of the dog small intestineT P Davis, A J Culling, H Schoemaker, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1983
Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidneyH Schoemaker, R G Boles, W D Horst, et al.
Ciba Foundation Symposium|January 1, 1986
Antidepressant-binding sites in brain and plateletsS Z Langer, A M Galzin, C R Lee, et al.
European Journal of Pharmacology|April 6, 1993
In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonistI Angel, A Grosset, G Perrault, et al.
CNS Spectrums|June 6, 2018
Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophreniaJoep H Schoemaker, Ad J J M Vingerhoets, Robin A Emsley
Behavioural Pharmacology|April 26, 2000
Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligandsG Griebel, G Perrault, S Tan, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Neuropharmacology|August 1, 1989
Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transportersA M De Oliveira, H Schoemaker, A Segonzac, et al.
European Journal of Pharmacology|March 25, 1983
In vivo identification of calcium antagonist binding sites using [3H]nitrendipineH Schoemaker, H R Lee, W R Roeske, et al.
Neuropharmacology|July 31, 1999
Pharmacological studies on synthetic flavonoids: comparison with diazepamG Griebel, G Perrault, S Tan, et al.
Clinical Neuropharmacology|January 1, 1992
The serotonin re-uptake transporter as a target for antidepressant actionS Z Langer, D Graham, S Arbilla, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1983
beta-Endorphin and its metabolites stimulate motility of the dog small intestineT P Davis, A J Culling, H Schoemaker, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1983
Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidneyH Schoemaker, R G Boles, W D Horst, et al.
Ciba Foundation Symposium|January 1, 1986
Antidepressant-binding sites in brain and plateletsS Z Langer, A M Galzin, C R Lee, et al.
European Journal of Pharmacology|April 6, 1993
In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonistI Angel, A Grosset, G Perrault, et al.
CNS Spectrums|June 6, 2018
Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophreniaJoep H Schoemaker, Ad J J M Vingerhoets, Robin A Emsley
Behavioural Pharmacology|April 26, 2000
Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligandsG Griebel, G Perrault, S Tan, et al.
Pageof 12